Purnell JQ. Definitions, classification, and epidemiology of obesity. Endotext [Internet]. 2023; https://www.ncbi.nlm.nih.gov/books/NBK279167/.

Kinlen D, Cody D, O’Shea D. Complications of obesity. QJM. 2018;111:437–443.

Article  CAS  PubMed  Google Scholar 

Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41:bnaa004.

Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord. 2013;14:219–27.

Article  CAS  PubMed  Google Scholar 

Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152–62.

Article  PubMed  Google Scholar 

Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and fantasies. J Clin Investig. 2019;129:3978–89.

Article  PubMed  PubMed Central  Google Scholar 

Mayoral LP, Andrade GM, Mayoral EP, Huerta TH, Canseco SP, Rodal Canales FJ, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res. 2020;151:11–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rey‐López JP, de Rezende LF, Pastor‐Valero M, Tess BH. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014;15:781–90.

Article  PubMed  Google Scholar 

Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020;8:616–27.

Article  PubMed  Google Scholar 

Stefan N, Schulze MB. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 2023;11:426–40.

Article  CAS  PubMed  Google Scholar 

Jelliffe D, Jelliffe E. Underappreciated pioneers. Quetelet: man and index. Am J Clin Nutr. 1979;32:2519–21.

Article  CAS  PubMed  Google Scholar 

Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol. 2018;72:1506–31.

Article  PubMed  Google Scholar 

van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9.

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Wang C, Guan S, Liu H, Wu X, Zhang Z, et al. The prevalence of metabolically healthy and unhealthy obesity according to different criteria. Obes Facts. 2019;12:78–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamer M, Bell JA, Sabia S, Batty GD, Kivimäki M. Stability of metabolically healthy obesity over 8 years: the English longitudinal study of ageing. Eur J Endocrinol. 2015;173:703–08.

Article  CAS  PubMed  Google Scholar 

Fanali G, Di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Asp Med. 2012;33:209–90.

Article  CAS  Google Scholar 

Luís C, Baylina P, Soares R, Fernandes R. Metabolic dysfunction biomarkers as predictors of early diabetes. Biomolecules. 2021;11:1589.

Article  PubMed  PubMed Central  Google Scholar 

Kunutsor SK, Apekey TA, Walley J, Kain K. Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence. Diabetes Metab Res Rev. 2013;29:308–18.

Article  CAS  PubMed  Google Scholar 

Zhang W, Zheng J, Zhang J, Li N, Yang X, Fang ZZ, et al. Associations of serum amino acids related to urea cycle with risk of chronic kidney disease in Chinese with type 2 diabetes. Front Endocrinol (Lausanne). 2023;14:1117308.

Article  PubMed  Google Scholar 

Kopelman P. Physiopathology of prolactin secretion in obesity. Int J Obes. 2000;24:S104–S108.

Article  CAS  Google Scholar 

Tanner MJ, Hadlow NC, Wardrop R. Variation of female prolactin levels with menopausal status and phase of menstrual cycle. Aust N Z J Obstet Gynaecol. 2011;51:321–4.

Article  PubMed  Google Scholar 

Turcotte AF, O’Connor S, Morin SN, Gibbs JC, Willie BM, Jean S, et al. Association between obesity and risk of fracture, bone mineral density and bone quality in adults: a systematic review and meta-analysis. PLoS One. 2021;16:e0252487.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lonardo A, Mantovani A, Lugari S, Targher G. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Ann Hepatol. 2020;19:359–66.

Article  CAS  PubMed  Google Scholar 

Pfortmueller CA, Uehlinger D, von Haehling S, Schefold JC. Serum chloride levels in critical illness—the hidden story. Intensive Care Med Exp. 2018;6:10.

Article  PubMed  PubMed Central  Google Scholar 

Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, et al. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab. 2000;278:E759–E768.

Article  CAS  PubMed  Google Scholar 

Hills CE, Brunskill NJ. Cellular and physiological effects of C-peptide. Clin Sci. 2009;116:565–74.

Article  CAS  Google Scholar 

Rossi MCE, Nicolucci A, Pellegrini F, Comaschi M, Ceriello A, Cucinotta D, et al. Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND Study. Nutr Metab Cardiovasc Dis. 2010;20:110–16.

Article  CAS  PubMed  Google Scholar 

Du N, Peng H, Chao X, Zhang Q, Tian H, Li H. Interaction of obesity and central obesity on elevated urinary albumin-to-creatinine ratio. PLoS One. 2014;9:98926.

Article  Google Scholar